gene therapy

News

Roche insists Spark deal is still on, despite lacklustre tak...

Shareholders in Spark Therapeutics haven’t been queueing up to take advantage of Roche’s $114.50-per-share offer, forcing an extension to the tender process.

News

health care icon pattern medical innovation concept background design

UK health innovations get £23m funding

The UK government’s Biomedical Catalyst (BMC) programme has announced £23 million of funding for cutting edge health projects, including new software which enables radiologists to diagnose

Views & Analysis

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Gene addition – a new chapter in treating rare diseases

The scientific advancements of the past 30 years have transformed our understanding of the potential of gene therapy and how it may be used to tackle rare diseases.

R&D

Will cell and gene therapies disrupt reimbursement?

Cell and gene therapies could prove disruptive in terms of the life-changing benefits they could bring to people with rare diseases and cancers – but they could also mean healthcare systems

News

Gene therapy biotech shares sink on inconclusive trial resul...

Shares in two US gene therapy biotechs have fallen after two cutting-edge treatments failed to produce convincing results in early clinical trials.

Digital

Deep Dive: Disruptive Technologies

In the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they're changing medicine, research and development, and healthcare, and how the pharmaceutical i

Roche insists Spark deal is still on, despite lacklustre tak...

UK health innovations get £23m funding

Gene addition – a new chapter in treating rare diseases

Will cell and gene therapies disrupt reimbursement?

Gene therapy biotech shares sink on inconclusive trial resul...

Deep Dive: Disruptive Technologies

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

gene therapy

Editor's Picks